The ENGAGE AF-TIMI @ ( Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction @ ) trial compared once-daily edoxaban to warfarin for stroke prevention in patients with AF .